Evidence map›Paper›PMID 29056364›Full record

ArticleExperimental neurology2018

Apolipoprotein E as a novel therapeutic neuroprotection target after traumatic spinal cord injury.

Xiaoxin Cheng, Yiyan Zheng, Ping Bu, Xiangbei Qi, Chunling Fan, Fengqiao Li, Dong H Kim, Qilin Cao

Open access · greenAbstract read
In one paragraph

Article in Experimental neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Xiaoxin ChengThe Vivian L Smith Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, TX 77030, USA; Center for Stem Cell and Regenerative Medicine, the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas Health Science Center at Houston, Houston, TX 77030, USA; Department of Cell Biology, Dalian Medical University, 25 Jinxin Road, Dalian, Liaoning 116033, China.
Yiyan ZhengThe Vivian L Smith Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, TX 77030, USA; Center for Stem Cell and Regenerative Medicine, the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Ping BuThe Vivian L Smith Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, TX 77030, USA; Center for Stem Cell and Regenerative Medicine, the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Xiangbei QiThe Vivian L Smith Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, TX 77030, USA; Department of Orthopaedic Trauma Center, the Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, China.
Chunling FanThe Vivian L Smith Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, TX 77030, USA; Department of Anatomy and Neurobiology, Xiangya School of Medicine, Central South University, Changsha, Hunan 410011, China.
Fengqiao LiCognosci Inc., Research Triangle Park, NC, USA.
Dong H KimThe Vivian L Smith Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, TX 77030, USA; Center for Stem Cell and Regenerative Medicine, the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Qilin CaoThe Vivian L Smith Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, TX 77030, USA; Center for Stem Cell and Regenerative Medicine, the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas Health Science Center at Houston, Houston, TX 77030, USA. Electronic address: qi-lin.cao@uth.tmc.edu.
The University of Texas Health Science Center at Houston · USBrown Foundation · USTriangle · US

Funding

In Vivo Reprogramming of Reactive Astrocyte and Chemogenetic Approach for SCI RepairR01NS099635 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI CAO, QI LIN · 2017 to 2021
$1.7M
NINDS NIH HHS R01 NS099635
6 · The paper itself

Abstract

Apolipoprotein E (apoE), a plasma lipoprotein well known for its important role in lipid and cholesterol metabolism, has also been implicated in many neurological diseases. In this study, we examined the effect of apoE on the pathophysiology of traumatic spinal cord injury (SCI). ApoE-deficient mutant (apoE

Indexed as

AnimalsApolipoproteins EApoptosisBlood-Air BarrierInflammationLeukocyte Common AntigensLocomotionLymphocytesMaleMiceMice, Inbred C57BLMice, KnockoutNeuronsNeuropeptidesNeuroprotectionOligodendrogliaApolipoproteins ELeukocyte Common AntigensNeuropeptidesApolipoprotein ENeuroprotectionSpinal cord-blood-barrierSpinal cord injuryTreatment

Identifiers

PMID29056364
PMCPMC5967384
OpenAlexW2766177283

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.